» Articles » PMID: 32420810

Circular RNA ABCB10 Promotes Non-small Cell Lung Cancer Progression by Increasing E2F5 Expression Through Sponging MiR-584-5p

Overview
Journal Cell Cycle
Specialty Cell Biology
Date 2020 May 19
PMID 32420810
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Background/aims: CircABCB10 function as an endogenous miRNA sponge plays an important role in various tumors. This experimental design was based on circABCB10 to explore the pathogenesis of non-small cell lung cancer (NSCLC). : CircRNA microarray was used to examine circRNA expression profiles in lung cancer from 3 NSCLC patients and paired healthy lung tissues. The expression of circABCB10 and miR-584-5p was detected by q-PCR. CCK-8, colony formation, and transwell assays to study the circABCB10 effects on tumor cell growth and cell migration invasiveness. To validate downstream target genes of circABCB10 and miR-584-5p detected by luciferase reporter assays. RT-qPCR and Western blotting were used to study E2F5 expression. The tumor growth was detected by nude mice in vivo. : We analyzed the human circRNA expression profile in NSCLC tissues. CircABCB10 was identified as a circRNA that increased in NSCLC tissues. CircABCB10 was noticeably raised in NSCLC, and high circABCB10 expression was related to low survival in NSCLC patients. Silencing of circABCB10 suppressed non-small cell lung cancer cell migration, cell proliferation, and invasion.CircABCB10 can act as a sponge of miR-584-5p to up-regulate E2F5 expression level. E2F5 knockdown or overexpress of miR-584-5p gene reversed the circABCB10 who has carcinogenic effects. There was a negative correlation expression between the circABCB10 and miR-584-5p gene, and There was a positive relationship between the expression of circABCB10 and E2F5 in NSCLC tumors. : CircABCB10 promoted the progression of NSCLC by modulating the miR-584-5p/E2F5 axis.

Abbreviation: NSCLC: non-small cell lung cancer; circ RNA: circular RNA; miRNA: micro RNA.

Citing Articles

Role of circular RNAs in cancer therapy resistance.

Liu W, Niu J, Huo Y, Zhang L, Han L, Zhang N Mol Cancer. 2025; 24(1):55.

PMID: 39994791 PMC: 11854110. DOI: 10.1186/s12943-025-02254-5.


Circular RNAs in lung cancer: implications for preventing therapeutic resistance.

Liu W, Sun Y, Huo Y, Zhang L, Zhang N, Yang M EBioMedicine. 2024; 107:105309.

PMID: 39191172 PMC: 11445705. DOI: 10.1016/j.ebiom.2024.105309.


Circular RNAs in Cell Cycle Regulation of Cancers.

Thamjamrassri P, Ariyachet C Int J Mol Sci. 2024; 25(11).

PMID: 38892280 PMC: 11173060. DOI: 10.3390/ijms25116094.


circRNA-CPA4 Regulates Cell Proliferation and Apoptosis of Non-small Cell Lung Cancer via the miR-1183/PDPK1 Axis.

Li H, Lei Y, Chen N, Guo G, Xiang X, Huang Y Biochem Genet. 2024; 62(5):4087-4102.

PMID: 38273153 DOI: 10.1007/s10528-023-10641-0.


Knockdown of RNA-binding protein IMP3 suppresses oral squamous cell carcinoma proliferation by destabilizing E2F5 transcript.

Wang Z, Zhang H, Li F, Huang C Aging (Albany NY). 2024; 16(2):1897-1910.

PMID: 38271139 PMC: 10866398. DOI: 10.18632/aging.205466.


References
1.
Li Y, Zheng Q, Bao C, Li S, Guo W, Zhao J . Circular RNA is enriched and stable in exosomes: a promising biomarker for cancer diagnosis. Cell Res. 2015; 25(8):981-4. PMC: 4528056. DOI: 10.1038/cr.2015.82. View

2.
Farazi T, Spitzer J, Morozov P, Tuschl T . miRNAs in human cancer. J Pathol. 2010; 223(2):102-15. PMC: 3069496. DOI: 10.1002/path.2806. View

3.
Shaw A, Yeap B, Mino-Kenudson M, Digumarthy S, Costa D, Heist R . Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK. J Clin Oncol. 2009; 27(26):4247-53. PMC: 2744268. DOI: 10.1200/JCO.2009.22.6993. View

4.
Polanowska J, Le Cam L, Orsetti B, Valles H, Fabbrizio E, Fajas L . Human E2F5 gene is oncogenic in primary rodent cells and is amplified in human breast tumors. Genes Chromosomes Cancer. 2000; 28(1):126-30. View

5.
Li P, Chen S, Chen H, Mo X, Li T, Shao Y . Using circular RNA as a novel type of biomarker in the screening of gastric cancer. Clin Chim Acta. 2015; 444:132-6. DOI: 10.1016/j.cca.2015.02.018. View